Kymera Therapeutics
KYMR
#1949
Rank
S$12.69 B
Marketcap
S$148.75
Share price
-3.42%
Change (1 day)
72.47%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): S-$4.65

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is S-$4.67. In 2025 the company made an earnings per share (EPS) of S-$4.75 a decrease over its 2024 EPS that were of S-$3.83.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.65-2.12%
2025S-$4.7523.91%
2024S-$3.8317.86%
2023S-$3.25-12.5%
2022S-$3.7239.81%
2021S-$2.6622.84%
2020S-$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA